Original language | English |
---|---|
Pages (from-to) | 77-86 |
Number of pages | 10 |
Journal | Clinical Therapeutics |
Volume | 35 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2013 Jan |
Bibliographical note
Funding Information:This study was sponsored by Dong-A Pharmaceutical Company Co, Ltd. The authors designed, conducted, interpreted, and wrote the manuscript under the supervision of Dr. H.-S. Kim and Dr. Hong. Drs. S.-H. Kim, Yoon, Choi, Hong, and H.-S. Kim conducted the enrollment of patients and contributed to clinical follow-up. Dr. Yoon, Choi, and Hong participated in the data analysis. Dr. Hong and Dr. H.-S. Kim contributed to the data interpretation. Drs. Seo, S.-H. Kim, Yoon, Choi, Hong, and H.-S. Kim contributed to the writing of the manuscript; all authors approved the final version.
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)